Product Information

LIRAGLUTIDE 2-PAK 18 MG/3 ML is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $25.6669 per ML under NDC 70748034602. Its NADAC has been published 50 times since Dec 10, 2025.

FDA first approved this application on Jul 22, 2025. Its Orange Book therapeutic-equivalence code is AP1.

LIRAGLUTIDE 2-PAK 18 MG/3 ML

Liraglutide
$25.6669per ML

Strength

6 mg/mL

NDC

70748034602

Classification

Generic

Dosage Form

INJECTION

Route

SUBCUTANEOUS

Effective Date

11/18/2026

Active Ingredients

LIRAGLUTIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA215421

FDA Approved

7/22/2025

TE Code

AP1

On Market Since

10/2/2025

Pharmacological Classes

GLP-1 Receptor Agonist
Glucagon-Like Peptide 1
Glucagon-like Peptide-1 (GLP-1) Agonists

Price Statistics

The NADAC for LIRAGLUTIDE 2-PAK 18 MG/3 ML has been published 50 times since Dec 10, 2025, and over the history we have for it it has declined 53.2%. The table below summarizes its recorded NADAC range and movement.

Current price$25.6669 per ML
All-time high$54.7952 (Dec 10, 2025)
All-time low$25.6669 (Nov 18, 2026)
52-week high$54.7952
52-week low$25.6669
Median price$38.5980
Average price$40.6514
Largest weekly change-11.1% (Apr 22, 2026)
Weeks tracked50
Tracking sinceDec 10, 2025

Price History

1W

-10.2%

1M

-18.3%

3M

-24.1%

6M

-33.5%

1Y

N/A

3Y

N/A

5Y

N/A

All

-53.2%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LIRAGLUTIDE 2-PAK 18 MG/3 ML?

The current National Average Drug Acquisition Cost (NADAC) for LIRAGLUTIDE 2-PAK 18 MG/3 ML, manufactured by Lupin Pharmaceuticals Inc., is $25.6669 per ML (NDC 70748034602), effective Nov 18, 2026.

How has the price of LIRAGLUTIDE 2-PAK 18 MG/3 ML changed over time?

Over the history we have for it, the NADAC for LIRAGLUTIDE 2-PAK 18 MG/3 ML has declined 53.2%. It has been tracked across 50 weekly CMS publications since Dec 10, 2025.

What are the highest and lowest recorded NADAC prices for LIRAGLUTIDE 2-PAK 18 MG/3 ML?

Since Dec 10, 2025, the NADAC for LIRAGLUTIDE 2-PAK 18 MG/3 ML has ranged from a low of $25.6669 (Nov 18, 2026) to a high of $54.7952 (Dec 10, 2025), with a median of $38.5980 per ML.

Are there cheaper alternatives to LIRAGLUTIDE 2-PAK 18 MG/3 ML?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LIRAGLUTIDE 3-PAK 18 MG/3 ML, is $25.4444 per ML — about 1% below LIRAGLUTIDE 2-PAK 18 MG/3 ML.

Who manufactures LIRAGLUTIDE 2-PAK 18 MG/3 ML?

LIRAGLUTIDE 2-PAK 18 MG/3 ML (NDC 70748034602) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.